What's Going On With Aptevo Therapeutics Stock Today?

Impact · against what's priced in

Aptevo Therapeutics faces significant downward pressure due to a combination of fundamental deterioration and technical distress. The company is implementing a 1-for-18 reverse stock split following a quarterly earnings miss and a widening year-over-year net loss.

APVO−0.70

No priced-in read yet

In context

The company is executing a 1-for-18 reverse split on December 29, coinciding with a quarterly loss of $2.23 per share that missed estimates and a net loss increase from $5.1 million to $7.5 million year-over-year.

Read from the article alone

• biotech
• healthcare
• APVO
• earnings miss
• net loss
• reverse split

Search tags